EQS-News: MEDIQON Group AG: Expansion of Equity Base to Accelerate Growth
|
EQS-News: MEDIQON Group AG
/ Key word(s): Corporate Action
MEDIQON Group AG: Expansion of Equity Base to Accelerate Growth
13.12.2022 / 10:02 CET/CEST
The issuer is solely responsible for the content of this announcement.
MEDIQON Group AG: Expansion of Equity Base to Accelerate Growth
As announced in the ad-hoc release of December 13, 2022, MEDIQON Group AG has successfully completed a capital increase.
The company raised EUR 15.5 million in equity by issuing 1,067,267 shares. The shares were subscribed by new shareholders as well as our long-term anchor investors.
The proceeds from the capital increase will be invested to further accelerate the Group’s growth.
Jan-Hendrik Mohr, CEO of MEDIQON Group AG commented:
"The platform companies of MEDIQON Group AG are growing stronger than expected. We are very pleased with the positive development of the Group in a challenging environment. We would like to thank our teams for the excellent job in developing the Group’s companies in 2022.“
Today's capital increase is a great vote of confidence from our shareholders and we welcome all new investors to the next chapter of our development!"
13.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
MEDIQON Group AG |
|
Herzog-Adolph-Strasse 2 |
|
61462 Königstein im Taunus |
|
Germany |
| Phone: |
+49 (0) 6174-9687040 |
| Fax: |
+49 (0) 6174-9687043 |
| E-mail: |
[email protected] |
| Internet: |
www.mediqon-group.de |
| ISIN: |
DE0006618309, DE000A254TL0 |
| WKN: |
661830, A254TL |
| Listed: |
Regulated Unofficial Market in Berlin, Frankfurt (Basic Board), Stuttgart |
| EQS News ID: |
1511677 |
| |
| End of News |
EQS News Service |
1511677 13.12.2022 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Umsatzerlöse1 |
3,21 |
2,64 |
0,10 |
1,08 |
28,66 |
42,07 |
70,77 |
| EBITDA1,2 |
0,72 |
8,99 |
-0,44 |
-0,61 |
6,21 |
10,50 |
10,80 |
| EBITDA-Marge3 |
22,43 |
340,53 |
-440,00 |
-56,48 |
21,67 |
24,96 |
|
| EBIT1,4 |
0,51 |
8,65 |
-5,51 |
-2,56 |
0,94 |
2,51 |
-1,68 |
| EBIT-Marge5 |
15,89 |
327,65 |
-5.510,00 |
-237,04 |
3,28 |
5,97 |
-2,37 |
| Jahresüberschuss1 |
0,54 |
7,51 |
-5,01 |
-2,27 |
-2,27 |
-6,60 |
-6,39 |
| Netto-Marge6 |
16,82 |
284,47 |
-5.010,00 |
-210,19 |
-7,92 |
-15,69 |
-9,03 |
| Cashflow1,7 |
0,75 |
7,85 |
-5,00 |
-1,13 |
2,87 |
5,69 |
7,37 |
| Ergebnis je Aktie8 |
0,24 |
3,04 |
-1,50 |
-0,18 |
0,38 |
0,05 |
-0,23 |
| Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: BDO
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Chapters Group |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| 661830 |
23,200 |
Kaufen |
533,28 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 44,62 |
17,40 |
2,63 |
92,80 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 2,67 |
72,40 |
7,54 |
49,73 |
| Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23
in % |
Hauptversammlung |
| 0,00 |
0,00 |
0,00 |
09.07.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
|
18.10.2024 |
|
27.05.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| -2,68% |
-0,08% |
26,78% |
37,28% |
|
|
MEDIQON Group AG DE0006618309